Guide to understanding the PSA - Pharmacy Guild of New Zealand

Guide to understanding the PsaPart C:Summary of Services to beprovidedFirst, this Part lists all of the Pharmacy Services thatmay be provided by contractor pharmacies and willbe publicly funded (C2.1):• Core and LTC Services• Specific Services (Class B Controlled Drug(Class B CD), Aseptic Pharmacy (Aseptic),Sterile Manufacturing (Sterile), Special Foods,Pharmacy Clozapine (Clozapine), ARRC,CPAM, Extemporaneously CompoundedPreparations (Extemp), NPPA A and B)• Other pharmacy services, if any – Part P.The detailed particulars that each Service consistsof, are found under the name of the Service inSchedule C1. At C2.2 (a) there is an agreement thatpharmacies will provide and claim for Core Services,unless the Service User is eligible for LTC Servicesor a Specific Service (C2.2 (a)). If a Service User isregistered for LTC Services or meets the criteria fora Specific Service, then the pharmacy will provideand be funded for those Services (C2.2 (b) and (c)).Some Specific Services, such as NPPA A, NPPA Band Extemp, will be funded in every communitypharmacy and are in effect part of Core and LTCServices. Some others, such as Aseptic, Sterile,Special Foods, Clozapine and CPAM services willonly be funded if the Specific Service is found at C2in Schedule C1 in the pharmacy’s particular PSA.To include an additional Specific Service at C2 inSchedule C1, pharmacies may be required to providesufficient information to demonstrate their ability toperform the Service (C2.3).Part C includes a commitment from both partiesto work together in good faith to support thetransition to the new model and refine the Servicesprovided under the Agreement (C2.4). There is alsoan agreement by Providers to participate in peerreview of Services provided by other Providers, andto work with CPSOG to develop audit and peerreview programmes (C2.5). Service User eligibilityis still determined against the same legislation, butthe clause on deciding eligibility to receive Serviceshas been expanded (C3.1). The method to determineeligibility and the entitlement to rely on prescribers’information is stated (C3.1 (b) (c)) and a websiteaddress to provide guidance is provided (C3.1 (d)).The clauses dealing with disputes (C3.2), providingServices to ineligible persons (C3.3) and changeof Premises (C4.2) remain the same. There is stilla restriction on providing services outside theDHB’s geographical area but the method to obtainpermission to do so is stated, as is the exception forthe occasional provision of Services to travellingnon-residents (C4.1 (b)).Schedule C1: Service specificationsCore Pharmacy Services – This Service Specificationreplaces “Base Pharmacy Services” from the previousPSA and is characterised by the DHBs as being largelyunchanged (CPSA 2012 Summary of Changes tothe Agreement). There are provisions dealing withopening hours (5.2) and waiting times (6.2). Theclause concerning dispensing specific brands reflectsrecent regulatory changes. The prescriber’s consentis no longer required for a pharmacist to substitutea generic for a Specific Brand unless “No brandsubstitution permitted” or similar is written (3.2(b)). Core Services include dispensing, advice andcounselling, record keeping, reporting to prescribers,administration according to the Procedures Manual,filling Practitioner Supply Orders (PSO), filling BulkSupply Orders (BSO) and Nicotine ReplacementTherapy (6.1). Pharmacy Methadone Services forOpioid Dependence (Methadone Services) areincluded in Core Services if provided on an adhoc or intermittent basis at patients’ request (6.1(i)). Methadone Services must still be provided inaccordance with the Service specification but unlessit is listed in clause 2 of Schedule C1, you can haveno more than two patients using the service at anyone time (6.1 (i) (iii)).Page 11